Cyclacel Pharmaceuticals (CYCC) 4.87 $0.00 (0.00%) 04:45PM (15 mins delay)


Mid-Afternoon Market Update: NovoCure Surges After Two-Year Survival Rate Increases For GBM Patients; Diffusion Pharma Shares Slide

Apr 03, 2017 - 2:44 PM EDT


Head over to Benzinga to read more

Source: Benzinga (Apr 03, 2017 - 2:44 PM EDT)




Make a suggestion for this page